Granzyme a is required for regulatory T-cell mediated prevention of gastrointestinal graft-versus-host disease
Resumen: In our previous work we could identify defects in human regulatory T cells (Tregs) likely favoring the development of graft-versus-host disease (GvHD) following allogeneic stem cell transplantation (SCT). Treg transcriptome analyses comparing GvHD and immune tolerant patients uncovered regulated gene transcripts highly relevant for Treg cell function. Moreover, granzyme A (GZMA) also showed a significant lower expression at the protein level in Tregs of GvHD patients. GZMA induces cytolysis in a perforin-dependent, FAS-FASL independent manner and represents a cell-contact dependent mechanism for Tregs to control immune responses. We therefore analyzed the functional role of GZMA in a murine standard model for GvHD. For this purpose, adoptively transferred CD4+CD25+ Tregs from gzmA-/- mice were analyzed in comparison to their wild type counterparts for their capability to prevent murine GvHD. GzmA-/- Tregs home efficiently to secondary lymphoid organs and do not show phenotypic alterations with respect to activation and migration properties to inflammatory sites. Whereas gzmA-/- Tregs are highly suppressive in vitro, Tregs require GZMA to rescue hosts from murine GvHD, especially regarding gastrointestinal target organ damage. We herewith identify GZMA as critical effector molecule of human Treg function for gastrointestinal immune response in an experimental GvHD model.
Idioma: Inglés
DOI: 10.1371/journal.pone.0124927
Año: 2015
Publicado en: PLoS One 10, 4 (2015), e0124927[9 pp]
ISSN: 1932-6203

Factor impacto JCR: 3.057 (2015)
Categ. JCR: MULTIDISCIPLINARY SCIENCES rank: 11 / 60 = 0.183 (2015) - Q1 - T1
Factor impacto SCIMAGO:

Financiación: info:eu-repo/grantAgreement/ES/MINECO-FEDER/SAF2011-25390
Tipo y forma: Article (Published version)
Área (Departamento): Inmunología (Departamento de Microbiología, Medicina Preventiva y Salud Pública)

Creative Commons You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Exportado de SIDERAL (2017-05-04-09:32:35)

Este artículo se encuentra en las siguientes colecciones:
Articles > Artículos por área > Inmunología

 Record created 2016-01-20, last modified 2017-05-04

Versión publicada:
Rate this document:

Rate this document:
(Not yet reviewed)